TxCell
Develops cell-based immuno-therapies for the treatment of severe chronic inflammatory diseases.
Launch date
Employees
Market cap
-
Enterprise valuation
$79m (Public information from Jul 2018)
Company register number 435361209
Valbonne Provence-Alpes-Côte d'Azur (HQ)
Authorizing premium user...